The active form of vitamin D3 can overcome the blood‐brain barrier and bind to vitamin D receptors in cerebral regions involved in depression, such as the prefrontal cortex and hypothalamus (Marsh et al., 2017). This evidence concerns the gene VDR and depressive symptom measurement.